90
Participants
Start Date
November 30, 2002
Primary Completion Date
March 31, 2004
Study Completion Date
November 30, 2010
IDEC-114
Dose Group 1 - 125 mg/m2 x 4 infusions \& 375 mg/m2 Rituxan x 4 infusions Dose Group 2 - 250 mg/m2 x 4 infusions \& 375 mg/m2 Rituxan x 4 infusions Dose Group 3 - 375 mg/m2 x 4 infusions \& 375 mg/m2 Rituxan x 4 infusions Dose Group 4 - 500 mg/m2 x 4 infusions \& 375 mg/m2 Rituxan x 4 infusions
Research site, Philadelphia
Research site, Boston
Research site, New York
Research site, Buffalo
Research site, Rochester
Research site, Washington D.C.
Research site, Charlottesville
Research site, Durham
Research site, Columbia
Research site, Tampa Bay
Research site, Birmingham
Research site, Detroit
Research site, Rochester
Research site, Maywood
Research site, Chicago
Research site, Omaha
Research site, Houston
Research site, Aurora
Research site, Tucson
Research site, Los Angeles
Research site, San Diego
Research site, Newport Beach
Lead Sponsor
Biogen
INDUSTRY